New device offers a convenient way to monitor compressed air for viable particles
Specialist cleanroom microbiology solutions company offers the new SAS Super Pinocchio CR compressed air sampling device.
Cherwell Laboratories has augmented its range of microbial air samplers with the addition of the SAS Super Pinocchio CR. This new air sampling device offers a more convenient way to monitor for viable particles in compressed air and other gas supplies used in controlled environments.
This updated version of the Pinocchio II compressed air sampling device can be fully dismantled for easy cleaning and decontamination — a process made more simple and effective by the device being manufactured in stainless-steel.
The Pinocchio CR provides a controlled method for bioburden monitoring of compressed air and other gases and can be included in an environmental monitoring program. It is ideal for use in manufacturing facilities where compressed air monitoring is falling under increasing regulatory scrutiny.
To ensure continuity with other environmental monitoring programs, the Pinocchio CR uses the same method of active air sampling as the rest of the SAS range of portable units. Using the multipoint impaction method of active sampling, air is aspirated through a perforated cover (a sampling head) and any particles present are impacted on to the agar surface of a contact plate or 90-mm Petri dish for subsequent culture.
This totally portable system, which is now more compact than the current Pinocchio II, does not require power and, therefore, can be used in high risk areas. Set up is simple as the Pinocchio CR is easily attached to an air or gas line, and a regulating valve controls the pressure delivered to the sampler. Airflow from the compressed supply is regulated through a flow meter before passing through its traditional SAS sampling head, with the unit capable of sampling 100 L/min.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance